about
Production and clinical development of nanoparticles for gene deliveryRNA Interference in the Age of CRISPR: Will CRISPR Interfere with RNAi?Impact of Nutrition on Non-Coding RNA Epigenetics in Breast and Gynecological CancerMechanistic Nanotherapeutic Approach Based on siRNA-Mediated DJ-1 Protein Suppression for Platinum-Resistant Ovarian CancerTrends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Docking Study.Inhibition of myeloid differentiation factor 88 signaling mediated by histidine-grafted poly(β-amino ester) ester nanovector induces donor-specific liver allograft tolerance.Stepping toward therapeutic CRISPR.Transdermal Delivery of siRNA through Microneedle ArrayBiodistribution and pharmacokinetics of Mad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer modelsAntibody h-R3-dendrimer mediated siRNA has excellent endosomal escape and tumor targeted delivery ability, and represents efficient siPLK1 silencing and inhibition of cell proliferation, migration and invasion.Functional inhibition of chemokine receptor CCR2 by dicer-substrate-siRNA prevents pain developmentDirect Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse OriginStructure-property relationship for in vitro siRNA delivery performance of cationic 2-hydroxypropyl-β-cyclodextrin: PEG-PPG-PEG polyrotaxane vectorsMolecular imaging and cancer gene therapy.Emerging potential of gene silencing approaches targeting anti-chondrogenic factors for cell-based cartilage repair.RNAi-mediated treatment of two vertically transmitted rhabdovirus infecting the salmon louse (Lepeophtheirus salmonis).Topical Glycyrrhizin Is Therapeutic for Pseudomonas aeruginosa Keratitis.A logic-based dynamic modeling approach to explicate the evolution of the central dogma of molecular biology.Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted "hsa-miR-2278" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A.Dendrimers Show Promise for siRNA and microRNA Therapeutics
P2860
Q26752803-ACBC071C-B849-47C8-AF41-10E4F34F0334Q26765460-66B514E7-D65D-448D-8B1B-334E7A14DB06Q27016123-2EDA5E91-FDD3-43E0-87AF-03F94C5D20F5Q29247912-075AF2A2-7916-4E93-B91C-3034FE9D9400Q30840924-6764F4CF-5C8E-4258-A5F3-3B7AA0681C70Q35846800-34F16F1D-39B1-40B0-A4B2-9EF0EF4DA262Q36419830-3869EDB0-BEAE-47FF-AC32-901BACC72508Q36591373-FF5A1010-BD33-4390-A32C-34304F1D3136Q37013417-B98A96C0-27FA-4582-99C1-8B5A30D797F1Q37046458-1796ACCD-B9A5-4187-866D-9891D5266867Q37115195-F6265484-2CF7-4D88-9A08-673D7923FA82Q37231321-49B99F30-A3AF-4C6A-B060-F820904C94D8Q38513174-D01C9A12-A894-40A2-B271-6FE6146B9F1FQ39011437-51DB1906-70E1-492A-B87A-8422793B762AQ39256778-E5F49174-C1FC-4623-A190-D582BA62C704Q42630029-C83F8C03-AB87-4B9D-9DA0-C70DF83E6919Q46242176-9A199EED-7B17-4D1A-9805-10E917610BC3Q47408918-85AD3B1E-091A-487C-8B82-71C67447AB91Q53513743-4C5FDBAC-DE48-4B0B-BC80-35C1607A9BAEQ58794827-58718DD5-FE2E-4887-9AAF-6C7D76CBCB42
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Therapeutic face of RNAi: in vivo challenges.
@en
type
label
Therapeutic face of RNAi: in vivo challenges.
@en
prefLabel
Therapeutic face of RNAi: in vivo challenges.
@en
P2860
P1476
Therapeutic face of RNAi: in vivo challenges.
@en
P2093
Saber Imani
Sadegh Azimzadeh Jamalkandi
P2860
P304
P356
10.1517/14712598.2015.983070
P407
P577
2014-11-15T00:00:00Z